Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes
Akio Monji, Toko Mitsui, Yoshiyuki Bando, et al.
AJP Heart and Circulatory Physiology (2013) Vol. 305, Iss. 3, pp. H295-H304
Closed Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Molecular mechanisms of diabetic cardiomyopathy
Heiko Bugger, E. Dale Abel
Diabetologia (2014) Vol. 57, Iss. 4, pp. 660-671
Open Access | Times Cited: 781
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America: This statement does not represent an update of the 2017 ACC/AHA/HFSA heart failure guideline update
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Circulation (2019) Vol. 140, Iss. 7
Open Access | Times Cited: 492
Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy
Zoltán V. Varga, Zoltán Giricz, Lucas Liaudet, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2014) Vol. 1852, Iss. 2, pp. 232-242
Open Access | Times Cited: 269
Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes
Eylem Levelt, Masliza Mahmod, Stefan K. Piechnik, et al.
Diabetes (2015) Vol. 65, Iss. 1, pp. 44-52
Open Access | Times Cited: 221
Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
Anne Dutour, Inès Abdesselam, Patricia Ancel, et al.
Diabetes Obesity and Metabolism (2016) Vol. 18, Iss. 9, pp. 882-891
Closed Access | Times Cited: 210
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Nikole J. Byrne, Namakkal S. Rajasekaran, E. Dale Abel, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 317-342
Open Access | Times Cited: 125
Of mice and men: models and mechanisms of diabetic cardiomyopathy
Christian Riehle, Johann Bauersachs
Basic Research in Cardiology (2018) Vol. 114, Iss. 1
Open Access | Times Cited: 155
Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America
Shannon M. Dunlay, Michael M. Givertz, David Aguilar, et al.
Journal of Cardiac Failure (2019) Vol. 25, Iss. 8, pp. 584-619
Closed Access | Times Cited: 121
Cardiovascular microRNAs: as modulators and diagnostic biomarkers of diabetic heart disease
Shruti Rawal, Patrick J. Manning, Rajesh Katare
Cardiovascular Diabetology (2014) Vol. 13, Iss. 1
Open Access | Times Cited: 103
Hydrogen sulfide attenuates high fat diet-induced cardiac dysfunction via the suppression of endoplasmic reticulum stress
Larry A. Barr, Yuuki Shimizu, Jonathan P. Lambert, et al.
Nitric Oxide (2015) Vol. 46, pp. 145-156
Open Access | Times Cited: 93
Diabetic cardiomyopathy: Pathophysiology, theories and evidence to date
Lavanya Athithan, Gaurav S. Gulsin, Gerry P McCann, et al.
World Journal of Diabetes (2019) Vol. 10, Iss. 10, pp. 490-510
Open Access | Times Cited: 78
Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases
Monika Barteková, Adriana Adameová, Anikó Görbe, et al.
Free Radical Biology and Medicine (2021) Vol. 169, pp. 446-477
Open Access | Times Cited: 74
GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage
Brady Park, Ehab Bakbak, Hwee Teoh, et al.
AJP Heart and Circulatory Physiology (2024) Vol. 326, Iss. 5, pp. H1159-H1176
Closed Access | Times Cited: 15
Exendin-4 protects adipose-derived mesenchymal stem cells from apoptosis induced by hydrogen peroxide through the PI3K/Akt–Sfrp2 pathways
Hao Zhou, Junjie Yang, Ting Xin, et al.
Free Radical Biology and Medicine (2014) Vol. 77, pp. 363-375
Closed Access | Times Cited: 74
Mitochondrial dysfunction and its impact on diabetic heart
Suresh K Verma, Venkata Naga Srikanth Garikipati, Raj Kishore
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1863, Iss. 5, pp. 1098-1105
Open Access | Times Cited: 72
Simultaneous Fluorescence Visualization of Endoplasmic Reticulum Superoxide Anion and Polarity in Myocardial Cells and Tissue
Haibin Xiao, Chuanchen Wu, Ping Li, et al.
Analytical Chemistry (2018) Vol. 90, Iss. 10, pp. 6081-6088
Closed Access | Times Cited: 72
Cardiac H2S Generation Is Reduced in Ageing Diabetic Mice
Sheng Jin, Shi-Xin Pu, Cuilan Hou, et al.
Oxidative Medicine and Cellular Longevity (2015) Vol. 2015, pp. 1-14
Open Access | Times Cited: 67
The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
Masliza Mahmod, Nikhil Pal, Jennifer J. Rayner, et al.
Journal of Cardiovascular Magnetic Resonance (2018) Vol. 20, Iss. 1, pp. 88-88
Open Access | Times Cited: 65
MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
Eylem Levelt, Gaurav S. Gulsin, Stefan Neubauer, et al.
European Journal of Endocrinology (2018) Vol. 178, Iss. 4, pp. R127-R139
Open Access | Times Cited: 64
Acacetin alleviates myocardial ischaemia/reperfusion injury by inhibiting oxidative stress and apoptosis via the Nrf-2/HO-1 pathway
Chan Wu, Ruo-Lan Chen, Yan Wang, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 553-561
Open Access | Times Cited: 30
Diabetes-Related Heart Failure
Yoshiyuki Bando, Toyoaki Murohara
Circulation Journal (2014) Vol. 78, Iss. 3, pp. 576-583
Open Access | Times Cited: 66
The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease
Huiting Gao, Zhigang Zeng, Han Zhang, et al.
Biological and Pharmaceutical Bulletin (2015) Vol. 38, Iss. 5, pp. 694-702
Open Access | Times Cited: 63
Honokiol protects against renal ischemia/reperfusion injury via the suppression of oxidative stress, iNOS, inflammation and STAT3 in rats
Yongwu Yu, MINGXV LI, Ning Su, et al.
Molecular Medicine Reports (2015) Vol. 13, Iss. 2, pp. 1353-1360
Open Access | Times Cited: 56
Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study
Preman Kumarathurai, Christian Anholm, Olav Wendelboe Nielsen, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 52
Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction
Milton Packer
Journal of Cardiac Failure (2019) Vol. 25, Iss. 12, pp. 986-1003
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top